In focus
Latest feed
Vertex Pharmaceuticals Makes a Major Play, Acquiring Crinetics in a Near-$5 Billion Deal
Biotech Power Play: Vertex's Bold Leap into Endocrine Therapies
A $10 Billion Shake-Up: Vertex Pharmaceuticals to Acquire Crinetics in Major Cash Deal
Vertex's Bold $10 Billion Bet: Reshaping the Biotech Landscape
